News Â鶹´«Ã½ from Johns Hopkins Medicine display Latest news from Johns Hopkins Medicine on News en-us Copyright 2024 News News Â鶹´«Ã½ from Johns Hopkins Medicine 115 31 / /images/newswise-logo-rss.gif Snuff Out Teen Smoking: Johns Hopkins Children's Center Expert Available for Interviews /articles/snuff-out-teen-smoking-johns-hopkins-children-s-center-expert-available-for-interviews/?sc=rsin /articles/snuff-out-teen-smoking-johns-hopkins-children-s-center-expert-available-for-interviews/?sc=rsin Thu, 14 Nov 2024 11:00:04 EST More than 10% of high school students in the U.S. smoke or use other tobacco products -- with most using e-cigarettes, according to the U.S. Food and Drug Administration's National Youth Tobacco Survey. Johns Hopkins Medicine Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers /articles/drug-combination-prompts-immune-response-in-some-resistant-pancreatic-cancers/?sc=rsin /articles/drug-combination-prompts-immune-response-in-some-resistant-pancreatic-cancers/?sc=rsin Thu, 14 Nov 2024 10:00:23 EST A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University. Johns Hopkins Medicine Johns Hopkins Researchers Use Electronic Diagnostic Model to Predict Acute Interstitial Nephritis (AIN) in Patients /articles/johns-hopkins-researchers-use-electronic-diagnostic-model-to-predict-acute-interstitial-nephritis-ain-in-patients/?sc=rsin /articles/johns-hopkins-researchers-use-electronic-diagnostic-model-to-predict-acute-interstitial-nephritis-ain-in-patients/?sc=rsin Tue, 12 Nov 2024 11:00:05 EST Researchers from both Johns Hopkins Medicine and Yale University collaborated on the development and application of a diagnostic model to detect acute interstitial nephritis (AIN) in patients, which could have a lasting impact on getting patients diagnosed earlier Johns Hopkins Medicine Johns Hopkins Medicine Study Expands Understanding of How Fecal Microbiota Transplants May Work to Restore Gut Health /articles/johns-hopkins-medicine-study-expands-understanding-of-how-fecal-microbiota-transplants-may-work-to-restore-gut-health/?sc=rsin /articles/johns-hopkins-medicine-study-expands-understanding-of-how-fecal-microbiota-transplants-may-work-to-restore-gut-health/?sc=rsin Wed, 06 Nov 2024 10:00:53 EST In a novel study that identified male chromosome genetic material in the intestines of female patients undergoing fecal transplants, researchers at Johns Hopkins Medicine say they have significantly expanded scientific understanding of how some of these transplants may succeed and work. Johns Hopkins Medicine Scientists Determine Why Some Patients Don't Respond Well to Wet Macular Degeneration Treatment, Show How New Experimental Drug Can Bridge Gap /articles/scientists-determine-why-some-patients-don-t-respond-well-to-wet-macular-degeneration-treatment-show-how-new-experimental-drug-can-bridge-gap/?sc=rsin /articles/scientists-determine-why-some-patients-don-t-respond-well-to-wet-macular-degeneration-treatment-show-how-new-experimental-drug-can-bridge-gap/?sc=rsin Wed, 06 Nov 2024 09:00:35 EST A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or "wet" AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used with existing wet AMD treatments to save vision. Johns Hopkins Medicine How Hypoxia Helps Cancer Spread /articles/how-hypoxia-helps-cancer-spread/?sc=rsin /articles/how-hypoxia-helps-cancer-spread/?sc=rsin Tue, 05 Nov 2024 11:30:21 EST Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop cancer recurrence, and one - MUC1 - is already in clinical trials. Johns Hopkins Medicine Fossil of Huge Terror Bird Offers New Information About Wildlife in South America 12 Million Years Ago /articles/fossil-of-huge-terror-bird-offers-new-information-about-wildlife-in-south-america-12-million-years-ago/?sc=rsin /articles/fossil-of-huge-terror-bird-offers-new-information-about-wildlife-in-south-america-12-million-years-ago/?sc=rsin Mon, 04 Nov 2024 01:00:00 EST Researchers including a Johns Hopkins University evolutionary biologist report they have analyzed a fossil of an extinct giant meat-eating bird -- which they say could be the largest known member of its kind -- providing new information about animal life in northern South America millions of years ago. Johns Hopkins Medicine Preventing Obesity in Very Young Children Could Be in the Palm of Parents' Hands /articles/preventing-obesity-in-very-young-children-could-be-in-the-palm-of-parents-hands/?sc=rsin /articles/preventing-obesity-in-very-young-children-could-be-in-the-palm-of-parents-hands/?sc=rsin Sun, 03 Nov 2024 17:05:00 EST A study co-led by a Johns Hopkins Children's Center clinician-researcher shows that adding text messaging and other electronic feedback to traditional in-clinic health counseling for parents about feeding habits, playtime and exercise prevents very young children from developing obesity and potentially lifelong obesity-related problems. Johns Hopkins Medicine Computational Tool Developed to Predict Immunotherapy Outcomes for Patients With Metastatic Breast Cancer /articles/computational-tool-developed-to-predict-immunotherapy-outcomes-for-patients-with-metastatic-breast-cancer/?sc=rsin /articles/computational-tool-developed-to-predict-immunotherapy-outcomes-for-patients-with-metastatic-breast-cancer/?sc=rsin Tue, 29 Oct 2024 14:00:06 EST Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy. Johns Hopkins Medicine Johns Hopkins Children's Center Expert Provides Tips for 'Falling Back' into Good Sleep Habits with Daylight Saving Time /articles/johns-hopkins-children-s-center-expert-provides-tips-for-falling-back-into-good-sleep-habits-with-daylight-saving-time/?sc=rsin /articles/johns-hopkins-children-s-center-expert-provides-tips-for-falling-back-into-good-sleep-habits-with-daylight-saving-time/?sc=rsin Tue, 29 Oct 2024 11:00:50 EST Daylight Saving Time ends Sunday, Nov. 3, so clocks will "fall back." This time of year can affect sleep schedules for anyone, including children. It's important to start planning ahead for the time change to help ensure children stay on track with their bedtime and get a good night's sleep. Johns Hopkins Medicine Johns Hopkins and Family of Henrietta Lacks Break Ground on Building Named in Honor of Henrietta Lacks /articles/johns-hopkins-and-family-of-henrietta-lacks-break-ground-on-building-named-in-honor-of-henrietta-lacks/?sc=rsin /articles/johns-hopkins-and-family-of-henrietta-lacks-break-ground-on-building-named-in-honor-of-henrietta-lacks/?sc=rsin Mon, 28 Oct 2024 11:45:11 EST The Johns Hopkins University and Johns Hopkins Medicine, together with descendants of Henrietta Lacks, broke ground today on the future site of the building named in honor of Mrs. Lacks, the Baltimore County woman whose HeLa cells have contributed to medical advancements around the world. Johns Hopkins Medicine Media Advisory: Johns Hopkins to Host Henrietta Lacks Building Groundbreaking Event /articles/media-advisory-johns-hopkins-to-host-henrietta-lacks-building-groundbreaking-event/?sc=rsin /articles/media-advisory-johns-hopkins-to-host-henrietta-lacks-building-groundbreaking-event/?sc=rsin Fri, 25 Oct 2024 08:00:36 EST Johns Hopkins University and Johns Hopkins Medicine, in collaboration with descendants of Henrietta Lacks, will honor the legacy of Mrs. Lacks and celebrate Hopkins' newest multidisciplinary space in East Baltimore with a groundbreaking ceremony for the building to be named in Henrietta Lacks' honor. Johns Hopkins Medicine Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors /articles/lymph-node-like-structures-may-trigger-the-demise-of-cancer-tumors/?sc=rsin /articles/lymph-node-like-structures-may-trigger-the-demise-of-cancer-tumors/?sc=rsin Fri, 25 Oct 2024 05:00:00 EST A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center. Johns Hopkins Medicine Johns Hopkins Children's Center Research in Mice Suggests Zinc Supplements Have Potential Value to Directly Treat Short Bowel Syndrome /articles/johns-hopkins-children-s-center-research-in-mice-suggests-zinc-supplements-have-potential-value-to-directly-treat-short-bowel-syndrome/?sc=rsin /articles/johns-hopkins-children-s-center-research-in-mice-suggests-zinc-supplements-have-potential-value-to-directly-treat-short-bowel-syndrome/?sc=rsin Thu, 24 Oct 2024 14:30:03 EST Researchers from Johns Hopkins Children's Center say they have identified a gene pathway involving the mineral zinc in mice that may someday point the way to using zinc-based supplements to directly help people with a rare disorder called short bowel syndrome (SBS). Johns Hopkins Medicine Two Johns Hopkins Faculty Members Elected to National Academy of Medicine /articles/two-johns-hopkins-faculty-members-elected-to-national-academy-of-medicine/?sc=rsin /articles/two-johns-hopkins-faculty-members-elected-to-national-academy-of-medicine/?sc=rsin Mon, 21 Oct 2024 14:00:06 EST Two faculty members at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health have been elected to the National Academy of Medicine (NAM). Christopher Chute, M.D., Dr.P.H., and Jeffrey Rothstein, M.D., Ph.D., join 100 new members of NAM. Johns Hopkins Medicine Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer from Progressing to More Dangerous States During Active Surveillance /articles/study-suggests-a-healthy-diet-may-help-keep-low-grade-prostate-cancer-from-progressing-to-more-dangerous-states-during-active-surveillance/?sc=rsin /articles/study-suggests-a-healthy-diet-may-help-keep-low-grade-prostate-cancer-from-progressing-to-more-dangerous-states-during-active-surveillance/?sc=rsin Thu, 17 Oct 2024 13:00:12 EST In a peer-reviewed study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a more aggressive state in men undergoing active surveillance -- a clinical option in which men with lower risk cancer are carefully monitored for progression in lieu of treatments that could have undesired side effects or complications. Johns Hopkins Medicine Study Finds HIV-To-HIV Kidney Transplants Are as Safe and Effective as Those Using Organs From Donors Without HIV /articles/study-finds-hiv-to-hiv-kidney-transplants-are-as-safe-and-effective-as-those-using-organs-from-donors-without-hiv/?sc=rsin /articles/study-finds-hiv-to-hiv-kidney-transplants-are-as-safe-and-effective-as-those-using-organs-from-donors-without-hiv/?sc=rsin Wed, 16 Oct 2024 17:15:29 EST According to findings from a multicenter study led by Johns Hopkins Medicine and released today in The New England Journal of Medicine (NEJM), transplanting kidneys from deceased donors who had the human immunodeficiency virus (HIV) to recipients with HIV is safe. Perhaps more importantly, the study authors also found that HIV-to-HIV kidney transplants are comparable in effectiveness to those using organs from donors without HIV. Johns Hopkins Medicine Immune Signatures May Predict Adverse Events from Immunotherapy /articles/immune-signatures-may-predict-adverse-events-from-immunotherapy/?sc=rsin /articles/immune-signatures-may-predict-adverse-events-from-immunotherapy/?sc=rsin Tue, 15 Oct 2024 13:00:45 EST Distinct immune "signatures" in patients who develop adverse events while taking immunotherapy for cancer may help oncologists identify patients at risk and treat them early to prevent serious side effects, suggests a study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. Johns Hopkins Medicine Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models /articles/experimental-cancer-drug-eliminates-bones-metastases-caused-by-breast-cancer-in-lab-models/?sc=rsin /articles/experimental-cancer-drug-eliminates-bones-metastases-caused-by-breast-cancer-in-lab-models/?sc=rsin Tue, 15 Oct 2024 09:00:02 EST In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses. Johns Hopkins Medicine Johns Hopkins Medicine Study Finds Commonly Used Arm Positions Can Substantially Overestimate Blood Pressure Readings /articles/johns-hopkins-medicine-study-finds-commonly-used-arm-positions-can-substantially-overestimate-blood-pressure-readings/?sc=rsin /articles/johns-hopkins-medicine-study-finds-commonly-used-arm-positions-can-substantially-overestimate-blood-pressure-readings/?sc=rsin Mon, 07 Oct 2024 11:00:00 EST Investigators say failing to follow arm support guidelines during BP screening could have significant clinical impact Johns Hopkins Medicine